<https://www.empr.com/home/news/drugs-in-the-pipeline/novel-antiviral-pimodivir-evaluated-in-patients-with-acute-uncomplicated-influenza-a/#webpage>
<http://schema.org/description>
"Pimodivir, an investigational first-in-class inhibitor of influenza virus polymerase basic protein 2 (PB2), was found to be beneficial in the treatment of acute uncomplicated influenza A virus infection in adult patients, according to the results of a Phase 2b study."
<https://www.empr.com/home/news/drugs-in-the-pipeline/novel-antiviral-pimodivir-evaluated-in-patients-with-acute-uncomplicated-influenza-a/>